Suppr超能文献

与1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)结构相关的异喹啉衍生物对复合体I的抑制作用

Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

作者信息

McNaught K S, Thull U, Carrupt P A, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden C D

机构信息

Neurodegenerative Diseases Research Centre, King's College, London, U.K.

出版信息

Biochem Pharmacol. 1995 Nov 27;50(11):1903-11. doi: 10.1016/0006-2952(95)02086-1.

Abstract

Mitochondrial respiratory failure secondary to complex I inhibition may contribute to the neurodegenerative process underlying nigral cell death in Parkinson's disease (PD). Isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium (MPP+) may be inhibitors of complex I, and have been implicated in the cause of PD as endogenous neurotoxins. To determine the potency and structural requirements of isoquinoline derivatives to inhibit mitochondrial function, we examined the effects of 22 neutral and quaternary compounds from three classes of isoquinoline derivatives (11 isoquinolines, 2 dihydroisoquinolines, and 9 1,2,3,4-tetrahydroisoquinolines) and MPP+ on the enzymes of the respiratory chain in mitochondrial fragments from rat forebrain. With the exception of norsalsolinol and N,n-propylisoquinolinium, all compounds inhibited complex I in a time-independent, but concentration-dependent manner, with IC50s ranging from 0.36-22 mM. Several isoquinoline derivatives were more potent inhibitors of complex I than 1-methyl-4-phenylpyridinium ion (MPP+) (IC50 = 4.1 mM), the most active being N-methyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline (IC50 = 0.36 mM) and 6-methoxy-1,2,3,4-tetrahydroisoquinoline (IC50 = 0.38 mM). 1,2,3,4-Tetrahydroisoquinoline was the least potent complex I inhibitor (IC50 approximately 22 mM). At 10 mM, only isoquinoline (23.1%), 6,7-dimethoxyisoquinoline (89.6%), and N-methylsalsolinol (34.8%) inhibited (P < 0.05) complex II-III, but none of the isoquinoline derivatives inhibited complex IV. There were no clear structure-activity relationships among the three classes of isoquinoline derivatives studied, but lipophilicity appears to be important for complex I inhibition. The effects of isoquinoline derivatives on mitochondrial function are similar to those of MPTP/MPP+, so respiratory inhibition may underlie their reported neurotoxicity.

摘要

继发于复合体I抑制的线粒体呼吸衰竭可能促使帕金森病(PD)中黑质细胞死亡背后的神经退行性过程。与1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)或1-甲基-4-苯基吡啶鎓(MPP+)结构相关的异喹啉衍生物可能是复合体I的抑制剂,并作为内源性神经毒素参与了PD的病因。为了确定异喹啉衍生物抑制线粒体功能的效力和结构要求,我们研究了来自三类异喹啉衍生物(11种异喹啉、2种二氢异喹啉和9种1,2,3,4-四氢异喹啉)的22种中性和季铵化合物以及MPP+对大鼠前脑线粒体片段中呼吸链酶的影响。除去甲去甲伪麻黄碱和N,n-丙基异喹啉鎓外,所有化合物均以时间无关但浓度依赖的方式抑制复合体I,IC50范围为(0.36 - 22 mM)。几种异喹啉衍生物是比1-甲基-4-苯基吡啶离子(MPP+)(IC50 = 4.1 mM)更有效的复合体I抑制剂,活性最高的是N-甲基-6-甲氧基-1,2,3,4-四氢异喹啉(IC50 = 0.36 mM)和6-甲氧基-1,2,3,4-四氢异喹啉(IC50 = 0.38 mM)。1,2,3,4-四氢异喹啉是效力最低的复合体I抑制剂(IC50约为22 mM)。在10 mM时,只有异喹啉(23.1%)、6,7-二甲氧基异喹啉(89.6%)和N-甲基去甲伪麻黄碱(34.8%)抑制(P < 0.05)复合体II - III,但没有一种异喹啉衍生物抑制复合体IV。在所研究的三类异喹啉衍生物之间没有明确的构效关系,但亲脂性似乎对复合体I抑制很重要。异喹啉衍生物对线粒体功能的影响与MPTP/MPP+的影响相似,因此呼吸抑制可能是其报道的神经毒性的基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验